iretrol-taj 100mg injection - Irinotecan (100mg) medicine

Irinotel 100mg Injection (Irinotecan): Comprehensive Medicine Guide

No reviews yet
🏭 Taj Pharma India Ltd 📦 Varies by brand 💊 Allopathy 📅 Updated: Sep 26, 2026
📋 Prescription Required 💊 Generic Available
Medically Reviewed
11 min read
Evidence: High
Reviewed by
SaathiMed Expert Panel | Sep 26, 2026
🩺
Medically Fact-Checked & Clinically Verified by SaathiMed Clinical Review Board
Clinical Reference Standards: CDSCO (Central Drugs Standard Control Organisation), Indian Pharmacopoeia (IP) & WHO | Last Updated: September 2026

When to Call Your Doctor IMMEDIATELY

  • Fever of 100.4°F (38°C) or higher
  • Severe diarrhea (more than 6 stools per day) or diarrhea with dehydration
  • Signs of severe allergic reaction: rash, hives, swelling of face or throat, difficulty breathing
  • Unusual bleeding or bruising
  • Yellowing of skin or eyes
  • Decreased urine output
  • New or worsening cough or shortness of breath

If experiencing severe symptoms, call emergency services immediately.

What is iretrol-taj 100mg injection used for?

This medicine is a chemotherapy drug used to treat metastatic colorectal cancer and other cancers. It works by blocking an enzyme needed for cancer cell DNA replication, leading to cell death. It is given by intravenous infusion under medical supervision.

  • Generic Name: Irinotecan (100mg)
  • Manufacturer: Taj Pharma India Ltd
  • Form: Allopathy
  • Pregnancy Category: Consult doctor
  • Prescription Required: Yes

🇮🇳 iretrol-taj 100mg injection के बारे में (Hindi Summary)

उपयोग: यह दवा इरिनोटेकन का इंजेक्शन है, जिसका उपयोग मुख्य रूप से मेटास्टेटिक कोलोरेक्टल कैंसर (आंत के कैंसर) के इलाज के लिए किया जाता है। यह कीमोथेरेपी की दवा है जो कैंसर कोशिकाओं के डीएनए को नष्ट करके उन्हें मरने में मदद करती है। यह दवा अस्पताल में डॉक्टर की देखरेख में नस के माध्यम से दी जाती है। यह फेफड़ों के कैंसर, पेट के कैंसर और अग्नाशय के कैंसर में भी कभी-कभी उपयोग की जाती है।

साइड इफेक्ट्स: इस दवा के सामान्य दुष्प्रभावों में दस्त, मतली, उल्टी, पेट दर्द, थकान, बुखार और रक्त कोशिकाओं की कमी शामिल हैं। गंभीर दस्त और संक्रमण का खतरा हो सकता है। अगर दस्त गंभीर हों या बुखार आए तो तुरंत डॉक्टर से संपर्क करें।

सुरक्षा सलाह: यह दवा केवल कैंसर रोग विशेषज्ञ की देखरेख में अस्पताल में ही दी जानी चाहिए। इसे घर पर स्वयं न लें। इलाज के दौरान नियमित रक्त परीक्षण करवाएं। गर्भवती महिलाओं और स्तनपान कराने वाली महिलाओं को यह दवा नहीं लेनी चाहिए। इलाज के दौरान शराब और अंगूर का सेवन न करें।

💡 Did You Know? Over 80% of the antiretroviral drugs used globally to combat AIDS are supplied by Indian pharmaceutical companies.

💊 iretrol-taj 100mg injection Uses & Benefits

[{"condition":"Metastatic colorectal cancer","description":"Used as first-line therapy in combination with other chemotherapy agents for metastatic colorectal cancer.","evidence":"Well-established"},{"condition":"Metastatic colorectal cancer (second-line)","description":"Used as a single agent for patients whose disease has progressed after initial chemotherapy.","evidence":"Well-established"},{"condition":"Small cell lung cancer","description":"Sometimes used in combination with other agents for extensive-stage small cell lung cancer.","evidence":"Moderate"},{"condition":"Pancreatic cancer","description":"Used in some regimens for advanced pancreatic cancer.","evidence":"Limited"},{"condition":"Gastric cancer","description":"Investigated in combination regimens for advanced gastric cancer.","evidence":"Limited"}]

Off-label uses: [{"condition":"Esophageal cancer","description":"Occasionally used in combination chemotherapy for advanced esophageal cancer.","evidence":"Limited"},{"condition":"Cervical cancer","description":"Sometimes used in recurrent or metastatic cervical cancer.","evidence":"Limited"},{"condition":"Glioblastoma","description":"Investigated in some brain tumor protocols.","evidence":"Limited"}]

Primary treatment for: Metastatic colorectal cancer

Also treats: Small cell lung cancer, Pancreatic cancer, Gastric cancer

📋 Drug Information

Generic Name(s)Irinotecan (100mg)
Brand Nameiretrol-taj 100mg injection
ManufacturerTaj Pharma India Ltd
Packaging / FormVaries by brand (Allopathy)
Therapeutic ClassANTI NEOPLASTICS
Action ClassTopoisomerase Inhibitor
Route of AdministrationParenteral (intravenous infusion)
StorageStore vials in a refrigerator at 2°C to 8°C (36°F to 46°F). Protect from light. Do not freeze. Once diluted, the infusion should be used within a specified time as per institutional guidelines.
Shelf LifeRefer to the product packaging for the exact shelf life. Typically 24 months from the date of manufacture when stored properly.
WHO GuidelineNot established from the available information.
ICMR GuidelineNot established from the available information.

👨‍⚕️ Doctor's Practical Tips

Evidence-based practical advice from experienced clinicians

1
Administer this medicine only under the supervision of a qualified oncologist.
2
Premedicate with antiemetics and atropine as appropriate to manage side effects.
3
Monitor complete blood counts before each cycle and adjust dose accordingly.
4
Educate patients on the importance of reporting diarrhea and fever immediately.
5
Consider UGT1A1 genotype testing to identify patients at higher risk of severe toxicity.
6
Avoid concomitant use of strong CYP3A4 inhibitors or inducers.
7
Ensure adequate hydration and electrolyte replacement in patients with diarrhea.

🔍 Is This Medicine Right for Your Symptom?

Educational reference. Always consult a doctor for diagnosis.

✅
Metastatic colorectal cancer
This medicine is commonly prescribed for this condition.
Likely Use
✅
Small cell lung cancer
This medicine may be used in combination therapy.
Likely Use
❌
Common cold
This medicine is not used for viral infections.
Not Primary

🔬 How This Medicine Works (Pharmacology)

Pharmacokinetics

AbsorptionThis medicine is administered intravenously, so absorption is not applicable. It is completely bioavailable after intravenous infusion.
DistributionIrinotecan and its metabolites are distributed widely in the body. The volume of distribution is moderate. It crosses the blood-brain barrier to a limited extent.
Protein BindingIrinotecan is approximately 30-68% bound to plasma proteins, while its active metabolite SN-38 is about 95% bound to plasma proteins, primarily albumin.
MetabolismIrinotecan is metabolized primarily in the liver by carboxylesterases to SN-38, which is then glucuronidated by UGT1A1 to inactive SN-38 glucuronide. Other metabolic pathways include CYP3A4-mediated oxidation.
Half-LifeThe elimination half-life of irinotecan is approximately 6 to 12 hours, while that of its active metabolite SN-38 is about 10 to 20 hours.
ExcretionThis medicine and its metabolites are excreted primarily in the bile and urine. About 20-50% of the dose is excreted in urine, and the remainder in feces.
BioavailabilityNot applicable for intravenous administration; bioavailability is 100% by this route.
Onset of ActionThe cytotoxic effects begin after conversion to SN-38, which occurs rapidly after infusion. Clinical effects such as tumor shrinkage may take weeks to become evident.
Peak Plasma TimePeak plasma concentrations of irinotecan are reached at the end of intravenous infusion. SN-38 peak levels occur shortly after.
Duration of ActionThe cytotoxic effect persists as long as the active metabolite is present in the body. The elimination half-life of SN-38 is about 10-20 hours, but the biological effect may last longer due to DNA damage.

How It Works

This medicine is a prodrug that is converted in the body to its active metabolite, SN-38. SN-38 binds to the topoisomerase I enzyme and stabilizes the enzyme-DNA complex, preventing the re-ligation of single-strand DNA breaks. This leads to DNA damage, inhibition of DNA replication, and ultimately cancer cell death. The medicine is cell cycle phase-specific, acting primarily in the S phase.

Mechanism Steps

1
Prodrug conversion: Irinotecan is converted by carboxylesterases in the liver and other tissues to its active metabolite, SN-38.
2
Topoisomerase I inhibition: SN-38 binds to the topoisomerase I-DNA complex and prevents the re-ligation of DNA strands.
3
DNA damage: The stabilization of the cleavable complex leads to irreversible DNA double-strand breaks during DNA replication.
4
Cell cycle arrest and apoptosis: The DNA damage triggers cell cycle arrest and programmed cell death (apoptosis) in cancer cells.

💡 How to Take iretrol-taj 100mg injection

Strength: 100 mg/5 mL concentrate for solution for infusion

1This medicine is given by a healthcare professional as an intravenous infusion.
2You will be monitored for allergic reactions during and after the infusion.
3Premedication with anti-nausea drugs may be given before the infusion.
4Report any side effects to your nurse or doctor immediately.
5Follow your doctor's instructions for blood tests and follow-up visits.

Dosage Information

Adult DosageThe dose of this medicine is individualized based on the type of cancer, combination with other drugs, and patient factors such as age, body surface area, liver function, and UGT1A1 genotype. Common regimens include 180 mg/m² or 125 mg/m² given intravenously over 90 minutes every 2 weeks, or 350 mg/m² every 3 weeks as a single agent. Dose must be individualized by a qualified clinician based on indication, age, weight, renal and hepatic function.
Pediatric DosagePediatric dosing is not established from available information. Consult a pediatric oncologist.
Elderly DosageElderly patients may be more sensitive to the effects of this medicine, especially diarrhea and bone marrow suppression. Dose adjustments may be necessary based on individual tolerance and organ function.
Renal ImpairmentNo specific dose adjustment is recommended for renal impairment, but caution is advised. Monitor kidney function closely.
Hepatic ImpairmentDose reduction is recommended in patients with liver impairment. For patients with bilirubin 1.0-2.0 mg/dL, a reduced dose is advised. For bilirubin >2.0 mg/dL, further reduction or avoidance may be needed. Consult a specialist.
Maximum Daily DoseThe maximum tolerated dose varies by regimen. As a single agent, up to 350 mg/m² every 3 weeks may be used. In combination, doses are lower. Do not exceed the dose prescribed by your oncologist.

Dosage Timeline

🌅 Morning ❌ ☀️ Afternoon ❌ 🌆 Evening ❌ 🌙 Night ❌

🍽️ Food Timing Guide

Grapefruit
Avoid
May increase irinotecan levels and toxicity.
St. John's Wort
Avoid
May decrease irinotecan levels and efficacy.
Alcohol
Avoid
May worsen liver toxicity and dehydration.

⏰ What to Do If You Miss a Dose

📌 If you miss a scheduled infusion appointment
→ Contact your oncology team as soon as possible to reschedule.
💡 Do not attempt to self-administer. Your treatment schedule may need adjustment.

⚠️ Side Effects of iretrol-taj 100mg injection

✅ Common Side Effects

Diarrhea (Very common (>10%))
Report immediately to your doctor. Use anti-diarrheal medication as prescribed. Maintain hydration.
Nausea and vomiting (Common (1-10%))
Take anti-nausea medicines as prescribed. Eat small, frequent meals.
Low white blood cell count (neutropenia) (Very common (>10%))
Regular blood tests are needed. Report fever or signs of infection immediately.
Fatigue (Common (1-10%))
Rest adequately. Balance activity with rest periods.
Abdominal pain (Common (1-10%))
Inform your doctor. Avoid heavy meals.

🚨 Serious Side Effects

Severe diarrhea (Common (1-10%))
Seek immediate medical attention if diarrhea is severe, persistent, or accompanied by dehydration.
Febrile neutropenia (Common (1-10%))
Go to the emergency room immediately if you have a fever of 100.4°F (38°C) or higher.
Severe allergic reaction (anaphylaxis) (Rare (<0.1%))
Seek emergency help if you experience rash, hives, swelling of face or throat, difficulty breathing.
Interstitial lung disease (Rare (<0.1%))
Report new or worsening cough, shortness of breath, or fever to your doctor immediately.
Blood clots (Uncommon (0.1-1%))
Seek immediate care for swelling, pain, or redness in an arm or leg, or sudden shortness of breath.

⚠️ Rare Side Effects

Severe skin reactions (Stevens-Johnson syndrome)
Seek immediate medical attention for rash, blisters, or peeling skin.
Liver toxicity
Report yellowing of skin or eyes, dark urine, or abdominal swelling.
Kidney failure
Report decreased urine output or swelling.
Severe constipation or ileus
Seek medical attention if you have severe abdominal pain and no bowel movement.

Consult your doctor if you experience any unusual symptoms.

🔬 Drug Interactions

Drug Severity Effect
Ketoconazole Major
Rifampin Major
Warfarin Moderate
Atazanavir Major
Live vaccines Major
Diuretics Moderate
Ondansetron Minor
Carbamazepine Major
Clarithromycin Major
Phenytoin Major

🚨 Major Interactions

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin)
  • Strong CYP3A4 inducers (e.g., rifampin, carbamazepine)
  • UGT1A1 inhibitors (e.g., atazanavir)
  • Live vaccines

⚡ Moderate Interactions

  • Warfarin
  • Diuretics
  • Other myelosuppressive agents

🍷 Alcohol Interaction

Alcohol may worsen liver toxicity and increase the risk of dehydration from diarrhea. It is advisable to avoid alcohol during treatment with this medicine.

🔎 Check Your Other Medicines

Educational tool. Always confirm with your doctor or pharmacist.

🛡️ Safety & Warnings

🚫 Contraindications

["Severe bone marrow suppression","Severe liver impairment","Known severe hypersensitivity to irinotecan or any component of the formulation","Pregnancy","Breastfeeding"]

⚠️ Warnings & Precautions

["This medicine should be administered only by a qualified oncologist.","Severe diarrhea can occur and may be life-threatening. Prompt treatment is essential.","Neutropenia is common; monitor blood counts closely.","Patients with UGT1A1*28 allele may be at increased risk of severe neutropenia and diarrhea.","Avoid live vaccines during treatment.","Use effective contraception during and after treatment.","Avoid grapefruit and St. John's Wort.","Report any signs of infection, bleeding, or allergic reaction immediately."]

🤱 Lactation Safety

It is not known whether this medicine is excreted in human milk. Because of the potential for serious adverse reactions in nursing infants, breastfeeding should be discontinued during treatment and for at least 1 month after the last dose.

💊 Overdose Management

There is no known antidote for overdose with this medicine. Management should be symptomatic and supportive. Patients should be monitored closely for bone marrow suppression, severe diarrhea, and dehydration. Hospitalization may be required.

⏰ Missed Dose

This medicine is given as an intravenous infusion in a hospital setting. If a scheduled dose is missed, contact your oncology team immediately to reschedule. Do not attempt to self-administer.

Additional Safety Advice

General Safety

This medicine must be given only under the supervision of a qualified oncologist in a hospital or cancer care center. Patients should not attempt to self-administer this medicine. Regular blood tests are essential to monitor blood cell counts, liver function, and kidney function. Patients should inform their doctor about all other medicines, supplements, and herbal products they are taking. Women of childbearing age should use effective contraception during treatment and for a period after the last dose. Men should also use contraception. Breastfeeding should be avoided during treatment. Patients should avoid close contact with people who have infections and should practice good hand hygiene. Adequate hydration and prompt treatment of diarrhea are important. Patients should not receive live vaccines during treatment.

👴 Special Considerations for Elderly

💡 For Patients Above 65

Elderly patients may be more susceptible to the side effects of this medicine, especially diarrhea, dehydration, and bone marrow suppression. Close monitoring and dose adjustments may be necessary.

🤰 Pregnancy Planning (TTC)

This medicine can cause fetal harm. Women should avoid becoming pregnant during treatment and for at least 6 months after the last dose. Men should avoid fathering a child during treatment and for at least 3 months after. Discuss contraception with your doctor.

🏥 Post-Surgery Considerations

This medicine may increase the risk of bleeding and infection after surgery. Inform your surgeon that you are receiving this medicine. Your treatment may need to be temporarily interrupted around the time of surgery.

🦷 Dental Procedures

This medicine can increase the risk of bleeding and infection. Inform your dentist that you are receiving this medicine. Dental procedures may need to be postponed until your blood counts recover.

💚 Lifestyle Tips for Better Results

🏃
Maintain a healthy diet rich in fruits, vegetables, and whole grains.
🥗
Stay well hydrated, especially if you have diarrhea.
😴
Get plenty of rest and pace your activities.
💧
Practice good hand hygiene to prevent infections.
🧘
Avoid crowds and people with infections.
🌞
Engage in light exercise as tolerated.
🚭
Keep a symptom diary to track side effects.

🏋️ Exercise Considerations

Exercise may need to be modified based on your energy levels and blood counts. Avoid strenuous activity if you have low blood counts or are feeling fatigued. Consult your doctor before starting any exercise program.

🥗 Diet Recommendations

Eat small, frequent meals to manage nausea.
Avoid spicy, greasy, or high-fiber foods if you have diarrhea.
Include bland, easy-to-digest foods like bananas, rice, applesauce, and toast.
Drink plenty of fluids to prevent dehydration.
Avoid grapefruit and grapefruit juice.
Limit alcohol consumption.

💼 Impact on Daily Work & Life

This medicine can cause fatigue, nausea, and diarrhea, which may affect your ability to work. You may need to take time off during treatment cycles. Discuss your work schedule with your employer and healthcare team. Avoid driving or operating heavy machinery if you feel dizzy or fatigued.

🛑 When to Stop This Medicine

Do not stop this medicine without consulting your oncologist. Treatment may be stopped or adjusted based on your response, side effects, or disease progression. If you experience severe side effects, contact your doctor immediately.

📅 Long-Term Use Effects

Long-term effects of this medicine may include persistent fatigue, increased risk of infections, and potential organ toxicity. Regular monitoring of blood counts, liver, and kidney function is essential. Some patients may experience delayed diarrhea. Long-term survivors should have regular follow-up with their oncologist.

🌿 Non-Medicine Approaches

These can complement medicine but do not replace prescribed treatment.

Other chemotherapy regimens

Depending on the cancer type and stage, other chemotherapy drugs or combinations may be used.

Evidence: Well-established
Targeted therapy

For some colorectal cancers, targeted therapies such as cetuximab or bevacizumab may be options.

Evidence: Well-established
Immunotherapy

In selected patients with certain genetic markers, immunotherapy may be considered.

Evidence: Moderate

💉 Vaccination Considerations

💉 If You're Getting Vaccinated

Live vaccines should not be administered during treatment with this medicine due to the risk of infection. Inactivated vaccines may be given, but their effectiveness may be reduced. Consult your doctor before receiving any vaccine.

📦 Storage Guide

✅ DO

Store in refrigerator at 2°C to 8°C

❌ DON'T

Do not freeze

✅ DO

Keep in original carton to protect from light

❌ DON'T

Do not use if the solution is discolored or contains particles

✅ DO

Follow institutional guidelines for diluted solution storage

❌ DON'T

Do not store diluted solution for extended periods

✈️ Traveling with This Medicine

This medicine is administered in a hospital setting, so travel should be planned around treatment cycles. If you need to travel, carry a copy of your prescription and medical records. Ensure that your destination has access to appropriate medical care. Store the medicine as directed by your healthcare provider. Check customs regulations for carrying prescription medications.

💰 Cost Analysis & Savings

👥 Real Patient Stories

Educational, anonymized scenarios. Individual results may vary.

👤 A 58-year-old man with metastatic colorectal cancer
He received this medicine in combination with other chemotherapy drugs. He experienced severe diarrhea after the first cycle but recovered with prompt treatment. He learned to keep anti-diarrheal medication on hand and to stay hydrated.
💡 Lesson: Early recognition and management of diarrhea are crucial to prevent complications.
👤 A 62-year-old woman with advanced pancreatic cancer
She was treated with this medicine as part of a clinical trial. She experienced fatigue and low blood counts, requiring dose reduction. She maintained a diary of symptoms and communicated regularly with her oncology team.
💡 Lesson: Open communication with the healthcare team helps tailor treatment and manage side effects effectively.

💬 Questions Patients Often Ask

Q: How long does it take for this medicine to work?

A: The effects of this medicine on cancer may take several weeks to become apparent. Your doctor will monitor your response with regular scans and tests.

Q: Can I drive after receiving this medicine?

A: This medicine can cause fatigue and dizziness. It is advisable to have someone else drive you to and from your appointments.

Q: What should I do if I miss a dose?

A: This medicine is given in a hospital setting. If you miss an appointment, contact your oncology team to reschedule as soon as possible.

Q: Is it safe to take this medicine during pregnancy?

A: No, this medicine can harm the fetus. It is not recommended during pregnancy. Use effective contraception during treatment.

🤔 Common Patient Concerns

💭 These are the concerns patients most commonly raise

  • Can I take this medicine if I have liver problems?
  • Will this medicine affect my fertility?
  • Can I work while on this medicine?
  • How long will I need to take this medicine?
  • What should I do if I experience diarrhea?
  • Is it safe to be around pregnant women while on this medicine?

🔄 Substitutes for iretrol-taj 100mg injection

View All

Alternative brands with exact same active ingredient:

Medical Note: Always consult your doctor before switching medications.

🛑 Myths vs. Facts

  • Myth: Irinotecan is a targeted therapy with no side effects.
    Fact: Irinotecan is a chemotherapy agent and can cause significant side effects, including severe diarrhea and low blood counts.
  • Myth: Irinotecan can be taken as a pill at home.
    Fact: Irinotecan is given as an intravenous infusion in a hospital or clinic setting.
  • Myth: Irinotecan is safe during pregnancy.
    Fact: Irinotecan can harm the fetus and is not recommended during pregnancy.

🔄 Alternative Options

Generic Alternatives

  • Irinotecan injection

Brand Alternatives

  • Irinotel 100mg injection

📊 Comparison with Similar Medicines

[{"medicine":"Irinotecan","class":"Topoisomerase I inhibitor","route":"Intravenous","main_use":"Colorectal cancer"},{"medicine":"Topotecan","class":"Topoisomerase I inhibitor","route":"Intravenous or oral","main_use":"Ovarian and lung cancer"},{"medicine":"Etoposide","class":"Topoisomerase II inhibitor","route":"Intravenous or oral","main_use":"Testicular and lung cancer"}]

😊 Was this information helpful?

Browse Medicines A-Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Back to Medicines Directory